Clinical trial
Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients
NCT00365612 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00365612 |
|---|---|
| Title | Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients |
| Official title | Phase IV, Open-Label, Randomized, Multicenter Study Evaluating Efficacy and Tolerability of Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir DF Compared to Unmodified HAART in HIV-1 Infected Subjects Who Have Achieved Virological Suppression on Their HAART Regimen |
| Lead sponsor | Gilead Sciences, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Efavirenz (EFV), Emtricitabine (FTC), Tenofovir DF (TDF) |
| Enrollment | 300 |
| Start date | Jul 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Aug 17, 2006 |
| Last update posted | Apr 10, 2008 |
| Countries | Puerto Rico, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: